M. Affronti

Allan H Friedman, James M Provenzale, R. McLendon, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A cross sectional analysis from a single institution’s experience of psychosocial distress and health-related quality of life in the primary brain tumor population

S. Keir, E. Lipp, H. Friedman, 2017, Journal of Neuro-Oncology.

A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

D. Berry, A. Berchuck, E. Shpall, 1996, Cancer Chemotherapy and Pharmacology.

Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy

J. Bubalo, M. Affronti, 2014, Cancer management and research.

Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.

L. Marks, E. Shpall, G. Broadwater, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial

E. Lipp, H. Friedman, A. Desjardins, 2021, Supportive Care in Cancer.

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

D. Bigner, H. Friedman, D. Reardon, 2009, Cancer.

Phase I I T rial o f T emozolomide i n P atients W ith P rogressive Low-Grade G lioma

R. McLendon, A. Friedman, D. Bigner, 2003 .

Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living with Low-grade Glioma.

E. Lipp, J. Herndon, M. Affronti, 2018, Seminars in oncology nursing.

Reducing Recovery Times in Outpatient Liver Biopsies

M. Affronti, Julie Thompson, P. Simon, 2022, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

D. Berry, E. Shpall, G. Broadwater, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

H. Friedman, A. Desjardins, J. Vredenburgh, 2016, Therapeutics and clinical risk management.

Improving Attitudes and Perceptions About End-of-Life Nursing on a Hospital-Based Palliative Care Unit.

Thomas J. Smith, M. Affronti, S. Schneider, 2019, Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association.

Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide

E. Lipp, H. Friedman, A. Desjardins, 2019, Supportive Care in Cancer.

Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses

R. Clark-Snow, C. Rittenberg, M. Affronti, 2017, Supportive Care in Cancer.

Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice

H. Friedman, M. Affronti, S. Schneider, 2014, Supportive Care in Cancer.

Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

E. Lipp, H. Friedman, A. Desjardins, 2019, Complementary therapies in clinical practice.

QOLP-29. MINDFULNESS MEDITATION PRACTICE IN MALIGNANT GLIOMA PATIENTS THROUGHOUT CONCOMITANT RADIATION AND TEMOZOLOMIDE: A FEASIBILITY STUDY

E. Lipp, H. Friedman, A. Desjardins, 2019, Neuro-Oncology.

Phase II study to evaluate the efficacy and safety of rilotumumab and bevacizumab (BEV) in subjects with recurrent malignant glioma (MG).

E. Lipp, H. Friedman, A. Desjardins, 2012 .

Spiritual well-being and its association with health-related quality of life in primary brain tumor patients.

E. Lipp, H. Friedman, A. Desjardins, 2021, Neuro-oncology practice.

Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review

A. Molassiotis, F. Scotté, I. Olver, 2023, Supportive Care in Cancer.

Development of a Professional Practice Model for Neuro-oncology Advanced Practitioners at an Academic Medical Center: A Quality Improvement Project

M. Affronti, Christina K. Cone, 2018, Journal of the advanced practitioner in oncology.

Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)

H. Friedman, J. Kirkpatrick, A. Desjardins, 2016, Supportive Care in Cancer.

Utilizing a Palliative Care Screening Tool in Patients With Glioblastoma

J. Herndon, M. Affronti, K. Peters, 2020, Journal of the advanced practitioner in oncology.

Interstitial chemotherapy with biodegradable BCNU (Gliadel®) wafers in the treatment of malignant gliomas

H. Friedman, A. Desjardins, D. Bota, 2007, Therapeutics and clinical risk management.

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

D. Bigner, H. Friedman, D. Reardon, 2009, Cancer.

2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies

M. Affronti, M. Fleury, A. Molassiotis, 2023, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.